BitMine Immersion Techs Stock (AMEX: BMNR)

Dernières nouvelles pour BitMine Immersion Techs (AMEX:BMNR) Stock

BitMine Immersion Technologies Inc is a blockchain technology company that is building out industrial-scale digital asset mining, equipment sales, and hosting operations. The company's primary business is data center focused, both mining Bitcoin for its account as well as hosting third-party Bitcoin mining servers. The Company's primary business is self-mining bitcoin for its own account, as well as hosting third-party equipment used in mining of digital asset coins and tokens, specifically bitcoin. Company's state of the art facilities will be specifically designed and constructed for housing mining equipment. The data centers will provide power, racks, proprietary thermodynamic management.

BitMine Immersion Technologies, Inc. Common Stock

BitMine Immersion Technologies Inc

- Purchases 4.9% of Great Elm Group's Common Stock; $150 Million Debt Investment in Monomoy Properties REIT to Accelerate Industrial Real Estate Platform Expansion –
- Company to Host Conference Call at 8:30 a.m. ET on August 1, 2025 -
Transaction Highlights:
<ul>
<li>Certain funds affiliated with Kennedy Lewis Investment Management LLC ("KLIM") purchase 4.9% of Great Elm Group, Inc's ("GEG") outstanding common stock at market price, approximately $2.11 per share.</li>
<li>$150 million of term loans in total strategic financing for Monomoy Properties REIT, LLC ("Monomoy REIT") from KLIM to catalyze growth across the Monomoy industrial real estate platform recently consolidated under Great Elm Real Estate Ventures, LLC ("Real Estate Ventures")</li>
<li>KLIM appoints board representatives at both GEG and Monomoy REIT, underscoring its commitment to a long-term partnership &nbsp;</li>
</ul>
PALM BEACH GARDENS, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- &nbsp;Great Elm Group, Inc. ("we," "us," "our," "GEG" or "Great Elm,") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEG#NASDAQ">GEG</a>), a publicly traded alternative asset manager, today announced a transformational strategic partnership with KLIM, an institutional alternative investment firm focused on opportunistic credit strategies including real estate with over $30 billion in assets under management. This partnership delivers up to $150 million in leverageable capital to support continued growth across Great Elm's real estate platform, which includes Monomoy REIT, Monomoy CRE (MCRE), Monomoy Construction Services (MCS), and Monomoy BTS (MBTS) (together "Monomoy"). Monomoy offers a full-service suite of project management, procurement, construction management, asset management, market analysis and feasibility services for its industrial real estate tenants.
Under the terms of the transaction, KLIM is providing an initial $100 million term loan to Monomoy REIT, and the option for an additional $50 million in future capital. Additionally, KLIM is purchasing 4.9% of GEG's common stock at market price, approximately $2.11 a share, and will hold an initial 15% profits interest (which may be increased to 20% under certain circumstances) in the newly formed Great Elm Real Estate Ventures, LLC, which consolidates GEG's real estate subsidiaries: MCRE, MCS, and MBTS.

News

Management

Kennedy Lewis Invests $150M In Monomoy REIT, Acquires 4.9% Stake In Great Elm Group To Accelerate Industrial Real Estate Growth

General

RKLB

Rocket Lab Opens Window For Its Next Mission For Multi-launch Customer, Institute For Q-shu Pioneers Of Space, Marking Electron's 69th Mission To Date And 11th Launch This Year

MODG

Topgolf Callaway Brands CEO Artie Starrs To Resign

<ul>
<li>Leqvio can now be used alone, without addition of statin therapy, as adjunct to diet and exercise for LDL-C reduction in patients with hypercholesterolemia (high LDL-C)1 &nbsp;</li>
<li>4 out of 5 atherosclerotic cardiovascular disease (ASCVD) patients do not reach guideline-recommended LDL-C target, reinforcing urgent need for more aggressive LDL-C lowering2-5 &nbsp;</li>
<li>Twice-yearly Leqvio is uniquely positioned to help support patient adherence and long-term LDL-C management, including goal attainment</li>
</ul>
Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio&#xAE; (inclisiran), enabling its use as monotherapy along with diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia1. The FDA proactively requested the label update based on the robust LDL-C lowering data for PCSK9-targeting therapies.
"This first-line label update reinforces Leqvio's proven ability to effectively lower LDL-C, a critical risk factor for heart disease," said Victor Bultó, President, US, Novartis. "With this new indication enabling Leqvio's use as monotherapy along with diet and exercise, we now have the potential to help even more patients achieve their LDL-C lowering goals earlier in their treatment journey."
With its twice-yearly, health care provider-administered dosing, Leqvio is uniquely positioned to help support patient adherence and long-term LDL-C management, including goal attainment. This is a critical unmet need, as up to 80% of ASCVD patients in the US struggle to reach the LDL-C guideline-recommended target of &lt;70 mg/dL2-5. This need is heightened by the latest 2025 ACC/AHA Joint Committee Clinical Practice Guideline for the Management of Patients with Acute Coronary Syndromes, which recommends more aggressive treatment to achieve LDL-C targets6.
The updated label removes the requirement for Leqvio to be used on top of or in combination with statin therapy1. Other updates include revising "primary hyperlipidemia" to the more specific term of "hypercholesterolemia" throughout the label, to more accurately focus on LDL-C reduction1.

Biotech

Novartis Announces That The U.S FDA  Has Approved A Label Update For Leqvio Allowing Its Use As Monotherapy Along With Diet And Exercise To Reduce Low-Density Lipoprotein Cholesterol In Adults With Hypercholesterolemia1.

Mirion Acquires Certrec For $81M

General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) has outperformed the market over the past 5 years by 1.76% on an annualized basis producing an average annual return of 15.63%. Currently, General Motors has a market capitalization of $50.78 billion. 
Buying $100 In GM: If an investor had bought $100 of GM stock 5 years ago, it would be worth $208.03 today based on a price of $53.34 for GM at the time of writing.
<h3>General Motors's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753994716_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In General Motors 5 Years Ago Would Be Worth This Much Today

Earnings

YSXT

YSX TECH. CO. 2025 Total Revenue $71.5M, Up 22%

Natuzzi S.p.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTZ#NYSE">NTZ</a>) ("Natuzzi" or the "Company") announced today that Mr. Antonio Achille, who has served as the Company's Chief Executive Officer and executive director since 2021, stepped down from his roles effective July 30, 2025, to pursue new professional opportunities.
Pending the appointment of a successor, the Board of Directors has temporarily delegated the CEO's powers and responsibilities to the Executive Chairman, Mr. Pasquale Natuzzi, who will serve in an interim capacity.

Natuzzi CEO Antonio Achille Resigns, Effective July 30, 2025; Board Temporarily Delegates CEO's Responsibilities To Executive Chairman, Pasquale Natuzzi

RBOT

Vicarious Surgical Appoints Stephen From As CEO

Azenta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZTA#NASDAQ">AZTA</a>) today announced that it has entered a collaboration with&nbsp;Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin genomic sequencing and data generation for Frenova's transformative MyReason&#xAE; genomics research program. This strategic collaboration aims to leverage cutting-edge technologies to enhance the understanding of cardio-kidney-metabolic diseases and drive advancements in precision medicine for patients worldwide.
The MyReason research program is an innovative initiative designed to uncover insights into the genetic mechanisms underlying kidney disease. To date, more than 35,000 participants have been registered in the program and provided biospecimens, with a goal of reaching 50,000 participants over the next two years.
Nephronomics holds exclusive commercial rights to the MyReason dataset, which anchors the Nephronomics Atlas, an unparalleled resource of deep clinical and genomic cardio-kidney-metabolic (CKM) disease data. Nephronomics aims to develop targeted therapies and redefine CKM disease care through precision medicine insights. By leveraging proprietary artificial intelligence (AI)/machine learning (ML) models trained on this comprehensive dataset, Nephronomics identifies novel disease subtypes, protective genetic variants, and therapeutic targets.
Azenta will support the collaboration by delivering genomic sequencing through GENEWIZ and managing long-term sample storage within its global biorepository network. With decades of experience in multiomics analysis and sample management solutions, Azenta is uniquely positioned to provide end-to-end solutions for complex research programs.

AZTA

Azenta Joins Frenova And Nephronomics To Power MyReason Genomics Program Aiming To Transform Precision CKM Disease Care

FBLG

FibroBiologics H1 2025 Net Loss ~$9.6M

BWXT

BWX Technologies Appoints Mike Fitzgerald As CFO

Gray Media has reached an agreement to acquire SagamoreHill Broadcasting's WLTZ, the NBC affiliate for the Columbus, Georgia, market (DMA 127), and KJTV, the FOX affiliate for the Lubbock, Texas, market (DMA 140). For the past several years, Gray has provided back-office services to both stations through its Columbus ABC affiliate WTVM and its Lubbock NBC affiliate KCBD, respectively.
Gray anticipates closing these transactions in the fourth quarter of this year following receipt of regulatory approval and other customary closing conditions. In that regard, Gray will request waivers of the FCC's current local broadcast ownership rule under the same "failing station" waiver standard through which the FCC has authorized similar combinations over the past 25 years, including earlier this year in connection with Gray's acquisition from SagamoreHill Broadcasting of KXLT, the FOX affiliated television station in the Rochester, Minnesota, market.

Gray Media Announces Agreement To Acquire SagamoreHill Broadcasting's Columbus , Georgia NBC Affiliate ALTZ And Lubbock, Texas Fox Affiliate KJTV, The Fox Affiliate For The Lubbock, Texas; Terms Not Disclosed

RARE

Ultragenyx Completes Enrollment In Its Phase 3 Aspire Study Of Apazunersen For Angelman Syndrome

Excelerate Energy, Inc. (the "Company" or "Excelerate") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EE#NYSE">EE</a>) announced today that its Board of Directors has declared a quarterly cash dividend, with respect to the quarter ended June 30, 2025, of $0.08 per share of Class A common stock, representing an approximately 33% increase from the prior quarter. The dividend is payable on September 4, 2025, to Class A common stockholders of record as of the close of business on August 20, 2025.

Dividends

Excelerate Energy Raises Quarterly Dividend By 33% From $0.06/Share To $0.08

FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), a leading global agricultural sciences company, today announced it has received registration for Fundatis&#xAE; herbicide powered by Isoflex&#xAE; active in Great Britain for use in winter wheat and winter barley. Isoflex&#xAE; active is a novel herbicide when used in cereals and is classified by the Herbicide Resistance Action Committee (HRAC) as a Group 13 herbicide. Fundatis&#xAE; herbicide provides growers with a new tool to help manage herbicide resistance across a wide range of agronomic practices.

FMC Corp. Receives Registration For Fundatis Herbicide Powered By Isoflex Active In Great Britain For Use In Winter Wheat And Winter Barley

INCY

Knight Therapeutics Submitted Supplemental Application To ANVISA For Approval Of Additional Indication For MINJUVI

WIIM

Clorox shares are trading higher after the company reported better-than-expected Q4 adjusted EPS and sales.

Strategic acquisition jumpstarts WisdomTree's entry into the private asset markets, with a focus on a high-growth $3.5 trillion U.S. farmland market and adjacent verticals, including solar, AI data infrastructure and water
Day 1 accretive transaction that accelerates long-term earnings growth potential
WisdomTree, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>), a global financial innovator, announced today that it entered into a definitive agreement to acquire Ceres Partners, LLC, a leading U.S.-based alternative asset manager specializing in farmland investments. This transaction marks WisdomTree's entry into the private asset markets—starting with real estate and specifically farmland—and positions WisdomTree as a category leader. Additionally, the Ceres farmland platform benefits from opportunities in strategic adjacencies in demand for solar, AI data infrastructure and water that are expected to drive faster growth.
The acquisition delivers immediate scale and long-term upside, bringing approximately $1.85 billion in assets under management across approximately 545 U.S. farmland properties spanning 12 states, predominantly in the Midwest. Ceres has a strong track record of performance, having delivered a 10.3% net average annual total return since its inception in 2007—outperforming farmland benchmarks.
With farmland recognized as one of the largest and most underpenetrated real asset classes in the U.S., WisdomTree believes there is significant opportunity for growth. The asset class historically provides resilient, inflation-protected returns and is largely uncorrelated to traditional equity and bond markets. As demand accelerates for income-generating, inflation-hedged private investments, this transaction well positions WisdomTree to offer differentiated access on an institutional scale. Farmland prices and asset values rose in the U.S. in all but nine years since World War II, and Ceres represents a value-added platform in a category that has the fundamentals for greater advisor and institutional adoption.
"Farmland is one of the largest yet most underpenetrated real asset classes in the U.S., offering both scale and scarcity," said Jonathan Steinberg, WisdomTree Founder and CEO. "This acquisition expands our leadership in innovative, income-generating investment solutions, while strategically accelerating our entry into private asset markets with a high-quality, scalable platform. It reflects our commitment to delivering differentiated exposures that drive long-term value for clients and stockholders alike. This strategic acquisition now positions WisdomTree to capitalize on the most significant structural growth opportunities in wealth and asset management today: ETPs, private markets, managed models and tokenization."
Perry Vieth, Founder and CEO, Ceres Partners, said, "We are proud of Ceres' long-standing partnerships and legacy with farmers. Joining forces with WisdomTree marks an exciting new chapter for Ceres. For nearly two decades, we've built a differentiated farmland investment platform rooted in performance, operational expertise and a deep understanding of U.S. agricultural markets. This partnership brings product innovation, scale and distribution that will allow us to reach more investors seeking resilient, inflation-hedged and income-generating real assets. Together, we are uniquely positioned to capitalize on the next wave of growth in farmland —including solar, AI data infrastructure and water—with a shared commitment to innovation and long-term value creation."

WisdomTree Announces Acquisition Of Ceres Partners; Terms Not Disclosed

COIN

Coinbase shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS and sales.

Press Releases

BitMine Immersion Technologies Announces $250 Million Private Placement to Initiate Ethereum Treasury Strategy; Expected to Become One of the Largest Publicly Traded ETH Holders

Synergy CHC Corp. (NASDAQ: SNYR) Secures Distribution Wins for FOCUSfactor® Supplements and Functional Beverages – More Stocks Inside

BitMine Immersion Technologies Closes $250 Million Private Placement to Advance its Treasury Strategy on Ethereum

Small Cap

BitMine Immersion Now Holds Approximately $500 Million of Ethereum to Advance its Ethereum Treasury Strategy

BitMine Immersion Now Holds Approximately $1 Billion of Ethereum(1) to Advance its Ethereum Treasury Strategy

ARK Invest Acquires $182 Million of BitMine Immersion (BMNR) Common Shares, Enabling BitMine to Further Advance its Ethereum Treasury Strategy

BitMine Immersion (BMNR) Announces Commencement of Options Trading on NYSE

Fintech

BitMine Immersion ETH Holdings Exceed $2 Billion of Ethereum to Advance its Ethereum Treasury Strategy

BitMine Immersion (BMNR) Announces Release of Investor Presentation and Launch of "Chairman's Message" Video Series

BitMine Immersion (BMNR) Announces $1 Billion Stock Repurchase Program

AMZN

ARTL

BMNR

COST

IPDN

PLUG

PNPNF

SNYR

TSXV:PNPN

WBUY

ACI Worldwide

Agilysys

C3.ai

Alarm.com Holdings

Asana

AvePoint

BILL Holdings

BlackLine

Blackbaud

BitMine Immersion Techs

Braze

Cleanspark

Freshworks

Intapp

IREN

Ncino

Pony AI Inc. - American Depositary Shares

Pony AI

D-Wave Quantum

Riot Platforms

SoundHound AI, Inc. - Class A Common Stock

SoundHound AI

SPS Commerce

Vertex

Workiva

Clear Secure

Zeta Global Holdings Corp. Class A Common Stock

Zeta Global Holdings

Comments

BitMine Immersion Techs

Actualités

Dernières nouvelles pour BitMine Immersion Techs (AMEX:BMNR) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL